ZIOPHARM Oncology, Inc.
(NASDAQ : ZIOP)

( )
ZIOP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.36%352.430.0%$5529.05m
BNTXBioNTech SE -2.97%351.740.0%$1554.09m
NVAXNovavax, Inc. 7.56%208.6378.2%$1149.83m
AMGNAmgen, Inc. -2.26%198.881.4%$591.30m
LGVNLongeveron Inc. 0.04%26.260.0%$511.78m
GILDGilead Sciences, Inc. -2.44%68.931.0%$497.91m
REGNRegeneron Pharmaceuticals, Inc. -2.73%636.532.7%$490.45m
VRTXVertex Pharmaceuticals, Inc. -1.67%186.941.9%$375.32m
SNSSSunesis Pharmaceuticals, Inc. 0.88%4.610.7%$322.26m
ILMNIllumina, Inc. -1.48%365.333.3%$311.28m
OCGNOcugen, Inc. -1.40%6.340.0%$293.70m
BIIBBiogen, Inc. -0.16%235.741.8%$289.61m
EXASEXACT Sciences Corp. -1.39%85.3718.0%$167.68m
INCYIncyte Corp. -3.77%67.722.4%$165.57m
BMRNBioMarin Pharmaceutical, Inc. -1.27%86.294.2%$144.64m

Company Profile

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.